![Robert D. Thompson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert D. Thompson
Chief Executive Officer at Lewis & Clark Pharmaceuticals, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Edward Williams | M | - |
Lewis & Clark Pharmaceuticals, Inc.
![]() Lewis & Clark Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Lewis & Clark Pharmaceuticals, Inc. develops adenosine receptor-based compounds. The firm focuses on A2A and A2B antagonists, and A2A agonists. It offers chemical synthesis and analysis, non-clinical dose formulation and plasma concentration analysis, assay development, toxicology and non-clinical consulting. The company was founded by Robert D. Thompson, David K. Glover and Julien Dimastromatteo in 2011 and is headquartered in Charlottesville, VA. | - |
Joel M. Linden | M | - |
Lewis & Clark Pharmaceuticals, Inc.
![]() Lewis & Clark Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Lewis & Clark Pharmaceuticals, Inc. develops adenosine receptor-based compounds. The firm focuses on A2A and A2B antagonists, and A2A agonists. It offers chemical synthesis and analysis, non-clinical dose formulation and plasma concentration analysis, assay development, toxicology and non-clinical consulting. The company was founded by Robert D. Thompson, David K. Glover and Julien Dimastromatteo in 2011 and is headquartered in Charlottesville, VA. | - |
Miette H. Michie | F | - |
Lewis & Clark Pharmaceuticals, Inc.
![]() Lewis & Clark Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Lewis & Clark Pharmaceuticals, Inc. develops adenosine receptor-based compounds. The firm focuses on A2A and A2B antagonists, and A2A agonists. It offers chemical synthesis and analysis, non-clinical dose formulation and plasma concentration analysis, assay development, toxicology and non-clinical consulting. The company was founded by Robert D. Thompson, David K. Glover and Julien Dimastromatteo in 2011 and is headquartered in Charlottesville, VA. | - |
Larry Rodman | M | - |
Lewis & Clark Pharmaceuticals, Inc.
![]() Lewis & Clark Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Lewis & Clark Pharmaceuticals, Inc. develops adenosine receptor-based compounds. The firm focuses on A2A and A2B antagonists, and A2A agonists. It offers chemical synthesis and analysis, non-clinical dose formulation and plasma concentration analysis, assay development, toxicology and non-clinical consulting. The company was founded by Robert D. Thompson, David K. Glover and Julien Dimastromatteo in 2011 and is headquartered in Charlottesville, VA. | 12 years |
C. Thomas Carter | M | - |
Lewis & Clark Pharmaceuticals, Inc.
![]() Lewis & Clark Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Lewis & Clark Pharmaceuticals, Inc. develops adenosine receptor-based compounds. The firm focuses on A2A and A2B antagonists, and A2A agonists. It offers chemical synthesis and analysis, non-clinical dose formulation and plasma concentration analysis, assay development, toxicology and non-clinical consulting. The company was founded by Robert D. Thompson, David K. Glover and Julien Dimastromatteo in 2011 and is headquartered in Charlottesville, VA. | - |
Jeffrey Totten | M | - |
Lewis & Clark Pharmaceuticals, Inc.
![]() Lewis & Clark Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Lewis & Clark Pharmaceuticals, Inc. develops adenosine receptor-based compounds. The firm focuses on A2A and A2B antagonists, and A2A agonists. It offers chemical synthesis and analysis, non-clinical dose formulation and plasma concentration analysis, assay development, toxicology and non-clinical consulting. The company was founded by Robert D. Thompson, David K. Glover and Julien Dimastromatteo in 2011 and is headquartered in Charlottesville, VA. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
David K. Glover | M | - |
Lewis & Clark Pharmaceuticals, Inc.
![]() Lewis & Clark Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Lewis & Clark Pharmaceuticals, Inc. develops adenosine receptor-based compounds. The firm focuses on A2A and A2B antagonists, and A2A agonists. It offers chemical synthesis and analysis, non-clinical dose formulation and plasma concentration analysis, assay development, toxicology and non-clinical consulting. The company was founded by Robert D. Thompson, David K. Glover and Julien Dimastromatteo in 2011 and is headquartered in Charlottesville, VA. | - |
Julien Dimastromatteo | M | - |
Lewis & Clark Pharmaceuticals, Inc.
![]() Lewis & Clark Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Lewis & Clark Pharmaceuticals, Inc. develops adenosine receptor-based compounds. The firm focuses on A2A and A2B antagonists, and A2A agonists. It offers chemical synthesis and analysis, non-clinical dose formulation and plasma concentration analysis, assay development, toxicology and non-clinical consulting. The company was founded by Robert D. Thompson, David K. Glover and Julien Dimastromatteo in 2011 and is headquartered in Charlottesville, VA. | - |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 8 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Robert D. Thompson
- Personal Network